Stem cell self-renewal: Lessons from bone marrow, gut and iPS toward clinical applications

Leukemia

Volumn 25, Issue 7, 2011, Pages 1095-1102

  Staal, F J T ^a   Baum, C ^b   Cowan, C ^c   Dzierzak, E ^d   Hacein Bey Abina, S ^e   Karlsson, S ^f   Lapidot, T ^g   Lemischka, I ^h   Mendez Ferrer, S ^h   Mikkers, H ^a   Moore, K ^h   Moreno, E ⁱ   Mummery, C L ^a   Robin, C ^d   Suda, T ^j   Van Pel, M ^a   Vanden Brink, G ^a   Zwaginga, J J ^a   Fibbe, W E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e Hô Pital Necker ^*  (France)

^f LUND UNIVERSITY   (Sweden)

^g WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ Centro Nacional de Investigaciones Oncológicas   (Spain)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

embryonic stem cell; gene therapy; iPS; stem cell; transplantation

Indexed keywords

BLOOD; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL REGENERATION; CELL RENEWAL; DNA MODIFICATION; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTESTINE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; STEM CELL; STEM CELL NICHE;

ADULT; ANIMALS; BONE MARROW CELLS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INTESTINES; MICE; NEOPLASTIC STEM CELLS; ORGAN SPECIFICITY; PATIENT SELECTION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 79960204113     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.52     Document Type: Review

References (74)

1. Pera MF, Tam PP. Extrinsic regulation of pluripotent stem cells. Nature 2010; 465: 713-720.
2. Blank U, Karlsson G, Karlsson S. Signaling pathways governing stem-cell fate. Blood 2008; 111: 492-503.
3. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006; 6: 93-106. (Pubitemid 43361585)
4. Issigonis M, Tulina N, de Cuevas M, Brawley C, Sandler L, Matunis E. JAK-STAT signal inhibition regulates competition in the Drosophila testis stem cell niche. Science 2009; 326: 153-156.
5. Fellous TG, Islam S, Tadrous PJ, Elia G, Kocher HM, Bhattacharya S et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology 2009; 49: 1655-1663.
6. Zhang J, Li L. Stem cell niche: microenvironment and beyond. J Biol Chem 2008; 283: 9499-9503.
7. Peerani R, Rao BM, Bauwens C, Yin T, Wood GA, Nagy A et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J 2007; 26: 4744-4755. (Pubitemid 350126801)
8. Conover JC, Notti RQ. The neural stem cell niche. Cell Tissue Res 2008; 331: 211-224. (Pubitemid 350265498)
9. Nemeth MJ, Bodine DM. Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways. Cell Res 2007; 17: 746-758. (Pubitemid 47409701)
10. Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev 2006; 2: 203-212. (Pubitemid 47109399)
11. Theise ND. The stem cell niche and tissue biology. Stem Cell Rev 2006; 2: 169-170. (Pubitemid 47109396)
12. Ninkovic J, Gotz M. Signaling in adult neurogenesis: from stem cell niche to neuronal networks. Curr Opin Neurobiol 2007; 17: 338-344. (Pubitemid 46887663)
13. Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, Park IH et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 2010; 115: 2769-2776.
14. Nakayama M. Homologous recombination in human iPS and ES cells for use in gene correction therapy. Drug Discov Today 2010; 15: 198-202.
15. Smith KP, Luong MX, Stein GS. Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol 2009; 220: 21-29.
16. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. (Pubitemid 44233629)
17. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872. (Pubitemid 350138099)
18. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
19. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318: 1920-1923.
20. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-1024. (Pubitemid 47517637)
21. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008; 453: 322-329. (Pubitemid 351693138)
22. Braam SR, Mummery CL. Human stem cell models for predictive cardiac safety pharmacology. Stem Cell Res 2010; 4: 155-156.
23. Freund C, Mummery CL. Prospects for pluripotent stem cellderived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 2009; 107: 592-599.
24. Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010; 16: 420-428.
25. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010; 24: 2239-2263.
26. Lemischka IR, Pritsker M. Alternative splicing increases complexity of stem cell transcriptome. Cell Cycle 2006; 5: 347-351.
27. MacArthur BD, Ma'ayan A, Lemischka IR. Toward stem cell systems biology: from molecules to networks and landscapes. Cold Spring Harb Symp Quant Biol 2008; 73: 211-215.
28. Macarthur BD, Ma'ayan A, Lemischka IR. Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol 2009; 10: 672-681.
29. Pritsker M, Doniger TT, Kramer LC, Westcot SE, Lemischka IR. Diversification of stem cell molecular repertoire by alternative splicing. Proc Natl Acad Sci USA 2005; 102: 14290-14295. (Pubitemid 41429691)
30. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953.
31. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945-949.
32. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801.
33. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521-531.
34. Kucia M, Reca R, Campbell FR, Zuba-Surma E, Majka M, Ratajczak J et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006; 20: 857-869.
35. Kucia M, Wysoczynski M, Ratajczak J, Ratajczak MZ. Identification of very small embryonic like (VSEL) stem cells in bone marrow. Cell Tissue Res 2008; 331: 125-134. (Pubitemid 350265493)
36. Ratajczak MZ, Shin DM, Ratajczak J, Kucia M, Bartke A. A novel insight into aging: are there pluripotent very small embryonic-like stem cells (VSELs) in adult tissues overtime depleted in an Igf-1-dependent manner? Aging (Albany NY) 2010; 2: 875-883.
37. Shin DM, Liu R, Klich I, Wu W, Ratajczak J, Kucia M et al. Molecular signature of adult bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast/germ line origin. Leukemia 2010; 24: 1450-1461.
38. Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev 2008; 22: 1856-1864. (Pubitemid 352008634)
39. van Dop WA, Heijmans J, Buller NV, Snoek SA, Rosekrans SL, Wassenberg EA et al. Loss of Indian hedgehog activates multiple aspects of a wound healing response in the mouse intestine. Gastroenterology 2010; 139: 1665-1676.
40. van Dop WA, Uhmann A, Wijgerde M, Sleddens-Linkels E, Heijmans J, Offerhaus GJ et al. Depletion of the colonic epithelial precursor cell compartment upon conditional activation of the hedgehog pathway. Gastroenterology 2009; 136: 2195-2203. e2191-e2197.
41. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009; 459: 262-265.
42. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010; 7: 11-14.
43. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010; 7: 20-24.
44. Dzierzak E. Opening act in a hematopoietic program. Blood 2009; 114: 229-230.
45. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996; 86: 897-906. (Pubitemid 26336794)
46. Cumano A, Dieterlen-Lievre F, Godin I. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell 1996; 86: 907-916. (Pubitemid 26336795)
47. de Bruijn MF, Ma X, Robin C, Ottersbach K, Sanchez MJ, Dzierzak E. Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity 2002; 16: 673-683. (Pubitemid 34626688)
48. Boisset JC, van CappellenW, Andrieu-Soler C, Galjart N, Dzierzak E, Robin C. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 2010; 464: 116-120.
49. Kissa K, Herbomel P. Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 2010; 464: 112-115.
50. Bertrand JY, Chi NC, Santoso B, Teng S, Stainier DY, Traver D. Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 2010; 464: 108-111.
51. Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009; 457: 887-891.
52. Aiuti A. Advances in gene therapy for ADA-deficient SCID. Curr Opin Mol Ther 2002; 4: 515-522. (Pubitemid 36305045)
53. Hacein-Bey S, Gross F, Nusbaum P, Yvon E, Fischer A, Cavazzana-Calvo M. Gene therapy of X-linked severe combined immunologic deficiency (SCID-X1). Pathol Biol (Paris) 2001; 49: 57-66. (Pubitemid 32174332)
54. Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer 2003; 3: 477-488. (Pubitemid 37328836)
55. Pike-Overzet K, van der Burg M, Wagemaker G, van Dongen JJ, Staal FJ. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol Ther 2007; 15: 1910-1916. (Pubitemid 350011729)
56. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. 20 years of gene therapy for SCID. Nat Immunol 2010; 11: 457-460.
57. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669-672. (Pubitemid 30241569)
58. Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004; 364: 2181-2187. (Pubitemid 40018447)
59. Deichmann A, Hacein-Bey-Abina S, Schmidt M, Garrigue A, Brugman MH, Hu J et al. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest 2007; 117: 2225-2232. (Pubitemid 47219567)
60. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008; 118: 3143-3150.
61. Schwarzwaelder K, Howe SJ, Schmidt M, Brugman MH, Deichmann A, Glimm H et al. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest 2007; 117: 2241-2249. (Pubitemid 47219569)
62. Montini E, Cesana D, Schmidt M, Sanvito F, Bartholomae CC, Ranzani M et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 2009; 119: 964-975.
63. Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009; 17: 1919-1928.
64. Modlich U, Schambach A, Brugman MH, Wicke DC, Knoess S, Li Z et al. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia 2008; 22: 1519-1528.
65. Staal FJ, Pike-Overzet K, Ng YY, van Dongen JJ. Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage? Leukemia 2008; 22: 1849-1852.
66. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978; 4: 7-25. (Pubitemid 8376317)
67. Fleming HE, Janzen V, Lo Celso C, Guo J, Leahy KM, Kronenberg HM et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2008; 2: 274-283. (Pubitemid 351298592)
68. Luis TC, Naber BA, Fibbe WE, van Dongen JJ, Staal FJ. Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling. Blood 2010; 116: 496-497.
69. Luis TC, Weerkamp F, Naber BA, Baert MR, de Haas EF, Nikolic T et al. Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood 2009; 113: 546-554.
70. Merchant A, Joseph G, Wang Q, Brennan S, Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010; 115: 2391-2396.
71. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010; 16: 232-236.
72. Himburg HA, Muramoto GG, Daher P, Meadows SK, Russell JL, Doan P et al. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat Med 2010; 16: 475-482.
73. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
74. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-1586. (Pubitemid 351626841)